Skip to main content

Table 6 Results of one-way sensitivity analyses.

From: Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Parameter modified

Value in BC

Value in SA

Scenario without B/N combination

Scenario with B/N combination

Difference (€) with B/N vs. without B/N

   

1 st year

2 nd year

3 rd year

1 st year

2 nd year

3 rd year

1 st year

2 nd year

3 rd year

Transition probabilities

See table 1

Same values for B/N combination than used for methadone

1,102

1,026

1,017

1,113

1,035

1,028

10.58

9.18

11.13

B/N combination uptakes

10%, 15% and 20% for 1st, 2nd and 3rd year

0.97%; 2.57% and 3.83% for 1st, 2nd and 3rd year

1,102

1,026

1,017

1,103

1,028

1,019

1.03

1.37

1.58

Initial proportion of patient distribution

HTP: 30% and LITP: 70%

HTP: 100%

1,477

1,185

1,127

1,513

1,204

1,144

35.260

19.13

16.46

  

LITP: 100%

941

958

970

941

960

973

0

1.76

3.44

Resource cost (cost per minute)

See table 3

+10%

1,201

1,126

1,116

1,218

1,129

1,119

7.78

2.87

2.30

  

-10%

995

926

918

1,008

937

930

13.38

11.08

12.39

  1. Yearly budgetary impact per patient (€, 2010)
  2. BC: Base Case; SA: Sensitivity analysis